Skip to main content Back to Top
Advertisement

7/12/2019

Cefepime Injection

Products Affected - Description

    • Maxipime powder for solution for injection, Pfizer, 1 gram, ADD-Vantage vial, 25 count, NDC 00409-0217-01
    • Maxipime powder for solution for injection, Pfizer, 1 gram, vial, 10 count, NDC 00409-0219-01
    • Maxipime powder for solution for injection, Pfizer, 2 gram, ADD-Vantage vial, 25 count, NDC 00409-0218-01
    • Maxipime powder for solution for injection, Pfizer, 2 gram, vial, 10 count, NDC 00409-0220-01
    • Cefepime injection, BBraun, 2 gram/100 mL, premixed bag, 24 count, NDC 00264-3195-11
    • Cefepime injection, Baxter, 2 gram/100 mL, premixed bag, 12 count, NDC 00338-1301-48
    • Cefepime powder for solution for injection, Sagent, 2 gram, vial, 10 count, NDC 25021-0122-50

Reason for the Shortage

    • Apotex has cefepime injection available.
    • Baxter has cefepime on allocation due to increased demand.
    • BBraun has cefepime on shortage due to manufacturing delays.
    • Fresenius Kabi has cefepime injection available.
    • Pfizer has Maxipime on shortage due to manufacturing delays.
    • Sagent has cefepime injection on shortage due to increased demand.
    • Samson Medical Technologies has cefepime injection available.
    • Sandoz discontinued cefepime injection in early-2016.
    • WG Critical Care has cefepime injection available.

Available Products

    • Cefepime powder for solution for injection, Apotex, 1 gram, vial, 1 count, NDC 60505-6146-00
    • Cefepime powder for solution for injection, Apotex, 1 gram, vial, 10 count, NDC 60505-6146-04
    • Cefepime powder for solution for injection, Apotex, 2 gram, vial, 1 count, NDC 60505-6147-00
    • Cefepime powder for solution for injection, Apotex, 2 gram, vial, 10 count, NDC 60505-6147-04
    • Cefepime injection, BBraun, 1 gram/50 mL, premixed bag, 24 count, NDC 00264-3193-11
    • Cefepime injection, Baxter, 1 gram/50 mL, premixed bag, 24 count, NDC 00338-1301-41
    • Cefepime powder for solution for injection, Fresenius Kabi, 1 gram, vial, 10 count, NDC 63323-0326-20
    • Cefepime powder for solution for injection, Fresenius Kabi, 2 gram, vial, 10 count, NDC 63323-0340-20
    • Cefepime powder for solution for injection, Sagent, 1 gram, vial, 10 count, NDC 25021-0121-20
    • Cefepime powder for solution for injection, Samson Medical Technologies, 100 gram, SmartPak bag, 1 count, NDC 66288-8100-01
    • Cefepime powder for solution for injection, WG Critical Care, 1 gram, vial, 10 count, NDC 44567-0240-10
    • Cefepime powder for solution for injection, WG Critical Care, 2 gram, vial, 10 count, NDC 44567-0241-10

Estimated Resupply Dates

    • Baxter has cefepime 2 gram premixed bags on allocation.
    • BBraun has cefepime 2 gram premixed bags on back order and the company estimates a release date of mid-July 2019.
    • Pfizer has Maxipime 1 gram and 2 gram vials and 1 gram and 2 gram ADD-Vantage vials on back order and the company estimates a release date of August 2020.
    • Sagent has cefepime 2 gram vials on back order and the company estimates a release date of July 2019.

Updated

Updated July 12, 2019 by Stephen Andrews, PharmD, BCPS, Drug Information Specialist. Created April 3, 2015 by Jane Chandramouli, PharmD, Drug Information Specialist. © 2019, Drug Information Service, University of Utah, Salt Lake City, UT.

Disclaimer

This information is provided through the support of Vizient to ASHP solely as a service to its members, which shall not use this information for their further commercial use. The content was prepared by the Drug Information Center of University of Utah. Vizient, ASHP, and the University of Utah make no representations or warranties, express or implied, including, but not limited to, any implied warranty of merchantability and/or fitness for a particular purpose, which respect to such information, and specifically disclaim all such warranties. Users of this information are advised that decisions regarding the use of drugs and drug therapies are complex medical decisions and that in using this information, each user must exercise his or her own independent professional judgment. Neither Vizient, ASHP nor the University of Utah assumes any liability for persons administering or receiving drugs or other medical care in reliance upon this information, or otherwise in connection with this bulletin. Neither Vizient, ASHP nor University of Utah endorses or recommends the use of any drug.

« Back to Drug Shortage Product Bulletins